Furthermore, BMP6 was down-regulated in drug-resistant cells, and knockdown of BMP6 in MCF-7 cells enhanced the chemoresistance to doxorubicin, indicating that BMP6 was a critical regulator of breast cancer drug resistance. Here, BMP6 is linked to breast carcinoma.